Chemkart India Ltd (544442)
Snapshot
The board meets on 30 Oct 2026 to consider the Q2 FY27 results.
Events
- Next results
- 30 Oct 2026 (Q2 FY27)
- Latest results
- H2 FY26
Exchange data. Each figure as its own page shows it; the dates are the data's. Information only, not investment advice.
📈 Share price & events
Q2 FY27 results
📅 Next results: 30 Oct 2026 (board meeting)Chemkart India Ltd's board meets on 30 Oct 2026 to consider its Q2 FY27 results (July-September 2026).
In its latest reported quarter, H2 FY26, Chemkart India's revenue was ₹112 Cr (+24.4% year on year, +8.7% on the previous half-year), and net profit ₹10.0 Cr (+11.1% year on year); the operating margin was 12.5%.
| H2 FY26 (₹ Cr) | Value | YoY vs H2 FY25 | vs prev. half |
|---|---|---|---|
| Revenue | ₹112 | +24.4% | +8.7% |
| Operating profit | ₹14.0 | +7.7% | +0.0% |
| Net profit | ₹10.0 | +11.1% | +0.0% |
| EPS (₹) | 7.86 | -16.1% | -6.3% |
| Operating margin | 12.5% | — | — |
📢 Recent Corporate Announcements
Chemkart India Limited has released its 7th Annual Report for FY2025-26, representing its first annual report post-IPO. The company reported FY26 revenue from operations of ₹21,259.48 Lakh (₹212.59 Cr), up from ₹20,327.85 Lakh (₹203.28 Cr) in FY25. The company's 7th Annual General Meeting is scheduled to be held on Saturday, September 19, 2026, via Video Conferencing.
- FY26 Revenue from Operations reported at ₹21,259.48 Lakh vs ₹20,327.85 Lakh in FY25
- 7th Annual General Meeting scheduled for September 19, 2026 at 12:00 PM IST via VC/OAVM
- First Annual Report dispatched to shareholders post Initial Public Offering (IPO)
Chemkart India Limited has issued the notice for its 7th Annual General Meeting scheduled for Saturday, September 19, 2026, via Video Conferencing. The cut-off date to determine e-voting eligibility has been set as September 12, 2026. Key agenda items include the adoption of FY26 financial statements, reappointment of director Mr. Shailesh Vinodrai Mehta, and appointment of statutory auditors M/s Prem Chand Jain & Co. for a 5-year tenure (FY27 to FY31).
- 7th AGM scheduled for September 19, 2026, at 12:00 PM IST via Video Conferencing
- Cut-off date for e-voting eligibility set for September 12, 2026
- Remote e-voting window runs from September 16, 2026 (09:00 AM IST) to September 18, 2026 (05:00 PM IST)
- Proposed appointment of Statutory Auditors M/s Prem Chand Jain & Co. for a 5-year term from FY27 to FY31
Chemkart India Limited has issued the notice for its 7th Annual General Meeting (AGM) scheduled for September 19, 2026, via Video Conferencing. Key agenda items include the adoption of FY26 audited standalone and consolidated financial statements, reappointment of director Mr. Shailesh Vinodrai Mehta, and appointment of M/s Prem Chand Jain & Co. as statutory auditors for a 5-year tenure (FY27 to FY31). Additionally, the company seeks shareholder approval to appoint M/s Nirmal Tiwari & Associates as secretarial auditor for 5 years. The cut-off date for e-voting is fixed for September 12, 2026.
- 7th Annual General Meeting scheduled for Saturday, 19th September 2026 at 12:00 PM IST via VC/OAVM
- E-voting cut-off date set as 12th September 2026; remote e-voting runs from 16th to 18th September 2026
- Proposal to appoint M/s Prem Chand Jain & Co., Chartered Accountants, as Statutory Auditors for 5 consecutive years (FY27 to FY31)
- Proposal to appoint M/s Nirmal Tiwari & Associates as Secretarial Auditor for a 5-year term from FY27 to FY31
- Re-appointment of promoter and Executive Director Mr. Shailesh Vinodrai Mehta (holding 1,30,807 shares), retiring by rotation
Chemkart India's Board of Directors has approved the appointment of M/s Prem Chand Jain & Co., Chartered Accountants, as Statutory Auditors for a 5-year term from FY 2026-27 to FY 2030-31. The Board additionally approved M/s Nirmal Tiwari & Associates as Secretarial Auditors for the same 5-year period. Both appointments are subject to shareholder approval at the upcoming 7th Annual General Meeting scheduled for September 19, 2026.
- Appointment of M/s Prem Chand Jain & Co. as Statutory Auditors for 5 consecutive years (FY 2026-27 to FY 2030-31)
- Appointment of M/s Nirmal Tiwari & Associates as Secretarial Auditors for 5 consecutive years (FY 2026-27 to FY 2030-31)
- Convening of the 7th Annual General Meeting on Saturday, September 19, 2026 at 12:00 PM IST via video conferencing
Chemkart India Limited announced the appointment of M/s Prem Chand Jain & Co., Chartered Accountants, as Statutory Auditors for a 5-year term covering FY 2026-27 to FY 2030-31, subject to shareholder approval. The company also appointed M/s Nirmal Tiwari & Associates as Secretarial Auditors for the same 5-year duration. Furthermore, the Board approved convening the 7th Annual General Meeting (AGM) on September 19, 2026, to formalize these appointments.
- Appointment of M/s Prem Chand Jain & Co. as Statutory Auditor for 5 consecutive years from FY 2026-27 to FY 2030-31
- Appointment of M/s Nirmal Tiwari & Associates as Secretarial Auditor for a 5-year term from FY 2026-27 to FY 2030-31
- 7th Annual General Meeting scheduled for Saturday, 19th September 2026 at 12:00 PM IST
Chemkart India Ltd has invested Rs 1.00 Crore in its wholly-owned subsidiary, Easy Raw Materials Private Limited, through a rights issue. This investment is a planned utilization of IPO proceeds aimed at commissioning a manufacturing unit for the subsidiary. Currently, the subsidiary is in a pre-operational stage with zero turnover and a loss of Rs 59.47 Lakhs for FY26. The investment is small, representing approximately 0.24% of Chemkart's TTM revenue of Rs 418 Cr.
- Investment of Rs 1.00 Crore for 10,00,000 equity shares at Rs 10 each
- Subsidiary turnover has been NIL for the last three financial years
- Subsidiary reported a Net Loss of Rs 59.47 Lakhs as of March 31, 2026
- Post-allotment paid-up share capital of the subsidiary is Rs 8.51 Crores
- Investment is funded through IPO proceeds as per the prospectus dated July 10, 2025
Chemkart India reported a robust start to FY27 with Q1 revenue reaching ₹99.60 crore, nearly 50% of the total revenue generated in the entire previous financial year. The company is aggressively transitioning from a distributor to an integrated manufacturer, with its EZRM facility completing plinth-level construction for Unit-1. Additionally, its subsidiary Vinstar Biotech has secured trial orders for in-house developed value-added ingredients, validating its R&D capabilities. The company added 15 key customers and currently has 20 R&D projects in the pipeline.
- Reported revenue of ₹99.60 crore for Apr-Jun FY27, representing nearly 50% of the previous full year's revenue.
- Added 15 key customers and initiated 20 R&D projects in the pipeline during the quarter.
- Completed plinth-level construction for Unit-1 of the EZRM manufacturing facility and received electricity sanction.
- Subsidiary Vinstar Biotech received trial orders for proprietary value-added ingredients from multiple customers.
- Targeting the Indian nutraceutical market projected to grow from $37-38 Bn in 2026 to $55-57 Bn by 2030.
Jaini Shailesh Mehta, a member of the promoter group of Chemkart India Ltd, acquired 1,200 equity shares through the open market on July 6, 2026. This transaction increased the individual's stake from 0.03% to 0.04% of the company's total equity. The acquisition involved a negligible portion of the total 1,20,99,000 equity shares. Such small-scale promoter group transactions are generally considered routine administrative disclosures.
- Acquisition of 1,200 equity shares via open market on July 6, 2026
- Individual promoter group holding increased from 4,207 shares (0.03%) to 5,407 shares (0.04%)
- Total equity share capital of the company remains at 1,20,99,000 shares of Rs 10 each
- Transaction represents approximately 0.01% of the total paid-up capital
Company profilewritten 13 Nov 2025
Financial Performance
Revenue Growth by Segment
No documents found
Geographic Revenue Split
No documents found
Profitability Margins
No documents found
EBITDA Margin
No documents found
Capital Expenditure
No documents found
Credit Rating & Borrowing
No documents found
Operational Drivers
Raw Materials
No documents found
Import Sources
No documents found
Key Suppliers
No documents found
Capacity Expansion
No documents found
Raw Material Costs
No documents found
Manufacturing Efficiency
No documents found
Logistics & Distribution
No documents found
Strategic Growth
Expected Growth Rate
No documents found
Growth Strategy
No documents found
Products & Services
No documents found
Brand Portfolio
No documents found
New Products/Services
No documents found
Market Expansion
No documents found
Market Share & Ranking
No documents found
Strategic Alliances
No documents found
External Factors
Industry Trends
No documents found
Competitive Landscape
No documents found
Competitive Moat
No documents found
Macro Economic Sensitivity
No documents found
Consumer Behavior
No documents found
Geopolitical Risks
No documents found
Regulatory & Governance
Industry Regulations
No documents found
Environmental Compliance
No documents found
Taxation Policy Impact
No documents found
Legal Contingencies
No documents found
Risk Analysis
Key Uncertainties
No documents found
Geographic Concentration Risk
No documents found
Third Party Dependencies
No documents found
Technology Obsolescence Risk
No documents found
Credit & Counterparty Risk
No documents found